These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7923886)

  • 1. Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity.
    Bernstein KA; Kahl LE; Balow JE; Lefkowith JB
    Clin Exp Immunol; 1994 Oct; 98(1):60-5. PubMed ID: 7923886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H; Ekblom-Kullberg S; Miettinen A
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
    Emad G; Al-Barshomy SM
    Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
    Picard C; Lega JC; Ranchin B; Cochat P; Cabrera N; Fabien N; Belot A
    Pediatr Nephrol; 2017 Sep; 32(9):1537-1545. PubMed ID: 28343355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus.
    Budhai L; Oh K; Davidson A
    J Clin Invest; 1996 Oct; 98(7):1585-93. PubMed ID: 8833907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y; Yang XW; Song Y; Yu F; Zhao MH
    Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.
    Meyer OC; Nicaise-Roland P; Cadoudal N; Grootenboer-Mignot S; Palazzo E; Hayem G; Dieudé P; Chollet-Martin S
    Arthritis Res Ther; 2009; 11(3):R87. PubMed ID: 19515233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
    Jaekell HP; Trabandt A; Grobe N; Werle E
    Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
    Yang XW; Tan Y; Yu F; Zhao MH
    Nephrol Dial Transplant; 2012 Sep; 27(9):3552-9. PubMed ID: 22700716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C1q in systemic lupus erythematosus.
    Stojan G; Petri M
    Lupus; 2016 Jul; 25(8):873-7. PubMed ID: 27252264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
    Elshweikh SA; Elkhouly RM; Shaalan MM; Shorbagy SH
    Egypt J Immunol; 2014; 21(2):49-59. PubMed ID: 25812352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
    Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M
    Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.